Targeting Loxosceles spider Sphingomyelinase D with small-molecule inhibitors as a potential therapeutic approach for loxoscelism

References

• Nicholson GM, Graudins A. Antivenoms for the treatment of spider envenomation. J Toxicol Rev 2003;22:35–59.
   Web of Science ®Google Scholar
• Isbister GK, Fan HW. Spider bite. Lancet 2011;378:2039–47.
   PubMed Web of Science ®Google Scholar
• Hubiche T, Delaunay P, del Giudice P. A case of Loxoscelism in Southern France. Am J Trop Med Hyg 2013;88:807–8.
   PubMed Web of Science ®Google Scholar
• Anwar S, Torosyan R, Ginsberg C. Clinicopathological course of acute kidney injury following brown recluse (Loxosceles reclusa) envenomation. Clin Kidney J 2013;6:609–12.
   PubMedGoogle Scholar
• Coutinho I, Rocha S, Ferreira ME, et al. Loxoscelismo Cutâneo em Portugal: Causa Rara de Dermonecrose. Acta Med Port 2014;27:654–57.
   PubMed Web of Science ®Google Scholar
• Zamani A, Rafinejad J. First record of the mediterranean recluse spider Loxosceles rufescens (Araneae: Sicariidae) from Iran. J Arthropod Borne Dis 2014;8:228–31.
   PubMed Web of Science ®Google Scholar
• Nag A, Datta J, Das A, et al. Acute kidney injury and dermonecrosis after Loxosceles reclusa envenomation. Indian J Nephrol 2014;24:246.
   PubMedGoogle Scholar
• Morales-Moreno HJ, Carranza-Rodriguez C, Borrego L. Cutaneous loxoscelism due to Loxosceles rufescens. J Eur Acad Dermatol Venereol 2016;30:1431–2.
   PubMed Web of Science ®Google Scholar
• Pezzi M, Giglio AM, Scozzafava A, et al. Spider bite: a rare case of acute necrotic arachnidism with rapid and fatal evolution. Case Rep Emerg Med 2016;2016:1–4.
   Google Scholar
• Tambourgi DV, Morgan BP, de Andrade RM, et al. Loxosceles intermedia spider envenomation induces activation of an endogenous metalloproteinase, resulting in cleavage of glycophorins from the erythrocyte surface and facilitating complement-mediated lysis. Blood 2000;95:683–91.
   PubMed Web of Science ®Google Scholar
• Atkins JA, Wingo CW, Flynn JE, et al. Necrotic Arachnidism. Am J Trop Med Hyg 1958;7:165–84.
   PubMed Web of Science ®Google Scholar
• Elston DM, Miller SD, Young RJ, et al. Comparison of colchicine, dapsone, triamcinolone, and diphenhydramine therapy for the treatment of brown recluse spider envenomation: a double-blind, controlled study in a rabbit model. Arch Dermatol 2005;141:595–7.
   PubMedGoogle Scholar
• Ministério da Saúde do Brasil. Manual de diagnóstico e tratamento de acidentes por animais peçonhentos. 2nd ed. Fundação Nacional de Saúde (Funasa), editor. Brasília; Brasília; 2001.
   Google Scholar
• Manzoni de Almeida D, Fernandes-Pedrosa MF, Gonçalves De Andrade RM, et al. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: Results of preclinical trials. Am J Trop Med Hyg 2008;79:463–70.
   PubMed Web of Science ®Google Scholar
• Tambourgi DV, Magnoli FC, van den Berg CW, et al. Sphingomyelinases in the venom of the spider Loxosceles intermedia are responsible for both dermonecrosis and complement-dependent hemolysis. Biochem Biophys Res Commun 1998;251:366–73.
   PubMed Web of Science ®Google Scholar
• Tambourgi DV, Paixão-Cavalcante D, Gonçalves De Andrade RM, et al. Loxosceles sphingomyelinase induces complement-dependent dermonecrosis, neutrophil infiltration, and endogenous gelatinase expression. J Invest Dermatol 2005;124:725–31.
   PubMed Web of Science ®Google Scholar
• Paixão-Cavalcante D, van den Berg CW, Fernandes-Pedrosa MF, et al. Role of matrix metalloproteinases in HaCaT keratinocytes apoptosis induced by Loxosceles venom sphingomyelinase D. J Invest Dermatol 2006;126:61–8.
   PubMed Web of Science ®Google Scholar
• Tambourgi DV, Gonçalves de Andrade RM, van den Berg CW. Loxoscelism: From basic research to the proposal of new therapies. Toxicon 2010;56:1113–9.
   PubMed Web of Science ®Google Scholar
• Murakami MT, Fernandes-Pedrosa MF, Tambourgi DV, et al. Structural basis for metal ion coordination and the catalytic mechanism of sphingomyelinases D. J Biol Chem 2005;280:13658–64.
   PubMed Web of Science ®Google Scholar
• de Andrade SA, Murakami MT, Paixão-Cavalcante D, et al. Kinetic and mechanistic characterization of the Sphingomyelinases D from Loxosceles intermedia spider venom. Toxicon 2006;47:380–6.
   PubMed Web of Science ®Google Scholar
• Tambourgi DV, Magnoli FC, Von Eickstedt VR, et al. Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway. J Immunol 1995;155:4459–66.
   PubMed Web of Science ®Google Scholar
• Tambourgi DV, De Sousa Da Silva M, Billington SJ, et al. Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases. Immunology 2002;107:93–101.
   PubMed Web of Science ®Google Scholar
• Corrêa MA, Okamoto CK, Gonçalves-De-andrade RM, et al. Sphingomyelinase D from Loxosceles laeta venom induces the expression of MMP7 in human keratinocytes: Contribution to dermonecrosis. PLoS One 2016;11:1–14.
   Web of Science ®Google Scholar
• Bucherl W. Biology and venoms of the most important South American spiders of the genera Phoneutria, Loxosceles, Lycosa, and Latrodectus. Am Zool 1969;9:157–9.
   PubMedGoogle Scholar
• Fernandes Pedrosa MF, Junqueira de Azevedo ILM, Gonçalves de Andrade RM, et al. Molecular cloning and expression of a functional dermonecrotic and haemolytic factor from Loxosceles laeta venom. Biochem Biophys Res Commun 2002;298:638–45.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75.
   PubMed Web of Science ®Google Scholar
• Irwin JJ, Sterling T, Mysinger MM, et al. ZINC: A free tool to discover chemistry for biology. J Chem Inf Model 2012;52:1757–68.
   PubMed Web of Science ®Google Scholar
• Irwin JJ, Shoichet BK. ZINC-a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005;45:177–82.
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000;28:235–42.
   PubMed Web of Science ®Google Scholar
• Jones G, Willett P, Glen R, et al. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997;267:727–48.
   PubMed Web of Science ®Google Scholar
• Verdonk ML, Chessari G, Cole JC, et al. Modeling water molecules in protein-ligand docking using GOLD. J Med Chem 2005;48:6504–15.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26.
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004;1:337–41.
   PubMedGoogle Scholar
• Walters WP. Going further than Lipinski’s rule in drug design. Expert Opin Drug Discov 2012;7:99–107.
   PubMed Web of Science ®Google Scholar
• Tokumura A, Kanaya Y, Miyake M, et al. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy. Biol Reprod 2002;67:1386–92.
   PubMed Web of Science ®Google Scholar
• Segel IH. Enzyme kinetics: behavior and analysis of rapid equilibrium and steady-state enzyme systems. 23393rd ed. John Wiley and Sons, ed. New York: Wiley-Interscience; 1993.
   Google Scholar
• Nagase H, Salvesen GS, Finding, purification and characterization of natural protease inhibitors. In: Beynon R, Bond SJ, eds. Proteolytic enzyme. 2nd ed. New York: Oxford University Press; 2001:359.
   Google Scholar
• Korb O, Stu¨tzle T, Exner TE. Empirical scoring functions for advanced protein-ligand docking with plants. J Chem Inf Model 2009;49:84–96.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• de Oliveira KC, Gonçalves de Andrade RM, Giusti AL, et al. Sex-linked variation of Loxosceles intermedia spider venoms. Toxicon 1999;37:217–21.
   PubMed Web of Science ®Google Scholar
• Gertsch WJ, Ennik F. The spider genus Loxosceles in North America, Central America, and the West Indies (Aranae, Loxoscelidae). Bull Am Museum Nat Hist 1983;175:264–360.
   Web of Science ®Google Scholar
• Rees RS, Nanney LB, Yates RA, et al. Interaction of brown recluse spider venom on cell membranes: the inciting mechanism? [Internet]. J Invest Dermatol 1984;83:270–5.
   PubMed Web of Science ®Google Scholar
• Wasserman GS, Anderson PC. Loxoscelism and Necrotic Arachnidism. J Toxicol Clin Toxicol 1983;21:451–72.
   PubMed Web of Science ®Google Scholar
• Hogan CJ, Barbaro KC, Winkel K. Loxoscelism: Old obstacles, new directions. Ann Emerg Med 2004;44:608–24.
   PubMed Web of Science ®Google Scholar
• Ribeiro VRD, Rúbio GBG, Konolsaisen JF, et al. Epidemiologia do acidente por aranhas do gênero Loxosceles Heinecken & Lowe no Estado do Paraná (Brasil). Mem Inst Butantan 1993;55(1):19–26.
   Google Scholar
• Pauli I, Puka J, Gubert IC, et al. The efficacy of antivenom in loxoscelism treatment. Toxicon 2006;48:123–37.
   PubMed Web of Science ®Google Scholar
• Rees R, Shack RB, Withers E, et al. Management of the brown recluse spider bite. Plast Reconstr Surg 1981;68:768–73.
   PubMed Web of Science ®Google Scholar
• Rees R, Campbell D, Rieger E, et al. The diagnosis and treatment of brown recluse spider bites. Ann Emerg Med 1987;16:945–9.
   PubMed Web of Science ®Google Scholar
• Andersen RJ, Campoli J, Johar SK, et al. Suspected brown recluse envenomation: a case report and review of different treatment modalities. J Emerg Med 2011;41:e31–7.
   PubMedGoogle Scholar
• Yokomatsu T, Murano T, Akiyama T, et al. Synthesis of non-competitive inhibitors of sphingomyelinases with significant activity. Bioorganic Med Chem Lett 2003;13:229–36.
   PubMed Web of Science ®Google Scholar
• Testai FD, Landek MA, Goswami R, et al. Acid sphingomyelinase and inhibition by phosphate ion: role of inhibition by phosphatidyl-myo-inositol 3,4,5-triphosphate in oligodendrocyte cell signaling. J Neurochem 2004;89:636–44.
   PubMed Web of Science ®Google Scholar
• Uchida R, Tomoda H, Dong Y, et al. Alutenusin, a Specific Neutral Sphingomyelinase Inhibitor, produced by Penicillium sp. FO-7436. J Antibiot (Tokyo) 1999;52:572–4.
   PubMed Web of Science ®Google Scholar
• Imagawa H, Oda M, Takemoto T, et al. Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors. Bioorganic Med Chem Lett 2010;20:3868–71.
   PubMed Web of Science ®Google Scholar
• Lee DH, Kim SH, Ahn KH, et al. Identification and evaluation of neutral sphingomyelinase 2 inhibitors. Arch Pharm Res 2011;34:229–36.
   PubMed Web of Science ®Google Scholar
• Berg J, Tymoczko J, Stryer L. Biochemistry. 6th ed. New York: W. H. Freeman and Co., 2007.
   Google Scholar
• Trengove NJ, Langton SR, Stacey MC. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 1996;4:234–9.
   PubMedGoogle Scholar
• Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993;101:64–8.
   PubMed Web of Science ®Google Scholar
• Reiss MJ, Han YP, Garcia E, et al. Matrix metalloproteinase-9 delays wound healing in a murine wound model. Surgery 2010;147:295–302.
   PubMed Web of Science ®Google Scholar
• Murakami MT, Fernandes-Pedrosa MF, de Andrade SA, et al. Structural insights into the catalytic mechanism of sphingomyelinases D and evolutionary relationship to glycerophosphodiester phosphodiesterases. Biochem Biophys Res Commun 2006;342:323–9.
   PubMed Web of Science ®Google Scholar